Funding for HIV network extended

June 1997
CMAJ: Canadian Medical Association Journal;06/01/97, Vol. 156 Issue 11, p1524
Academic Journal
Reports on the extension of the federal government's stable funding for the Canadian HIV Trials Network (CTN). Research projects of the organization; National director of the group.


Related Articles

  • A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-noninfected... Perry, R.T.; Plowe, C.V.; Koumaré, B.; Bougoudogo, F.; Kotloff, K.L.; Losonsky, G.A.; Wasserman, S.S.; Levine, M.M. // Bulletin of the World Health Organization;1998, Vol. 76 Issue 1, p63 

    Provides information on randomized clinical trials conducted in Mali on adults who are infected with the Human Immunodeficiency Virus (HIV), with focus on the use of a single dose of live oral cholera vaccine. Details on the seventh cholera pandemic caused by Vibrio cholerae; Methodology used...

  • One STEP forward, two steps back.  // AIDS Alert;Jun2008, Vol. 23 Issue 6, p68 

    The article reports that the STEP trial, a scientific concept tested in the HIV vaccine, did not produce the desired beneficial effect, according to Anthony S. Fauci, director at the National Institute of Allergy and Infectious Diseases National Institutes of Health (NIAID).

  • HIV trials instructive to other researchers.  // AIDS Alert;Sep2009, Vol. 24 Issue 9, p103 

    The article reports on the effort of HIV investigators and research sponsors to develop new ways to educate communities about HIV clinical trials in the U.S.

  • Placebos and HIV. Levine, Carol // Hastings Center Report;Nov/Dec98, Vol. 28 Issue 6, p43 

    Provides information on the placebo-controlled trials of zidovudine (AZT) to prevent mother-to-child HIV transmission in developing countries. Trial methodology and the ethical use of placebos; Arguments in favor of the trials; Arguments opposing the trials.

  • A World of Research Subjects. Emanuel, Ezekiel J. // Hastings Center Report;Nov/Dec98, Vol. 28 Issue 6, p25 

    Introduces series of articles on the controversy surrounding the maternal-fetal HIV transmission studies in developing countries.

  • Scientists get step closer to HIV vaccine. Yingqi, Cheng // US-China Today;4/4/2011, p2 

    The article reports on China's leading disease control expert, according to whom, Chinese scientists have been successful in completing first phase of a clinical trial of a human immunodeficiency viruses (HIV) vaccine. Shao Yiming, chief expert of the National Center for AIDS/STD Control and...

  • Drug firms donate compounds for anti-HIV gel. Towie, Narelle // Nature;11/3/2005, Vol. 438 Issue 7064, p6 

    Reports that two drug companies have given away rights to two key compounds for anti-HIV gel. Protection of women using the gel; Number of lives that could be saved with its use; Clinical trials in Africa on monkeys.

  • Microbicides 2008.  // HIV Australia;Dec2006, Vol. 6 Issue 2, p5 

    The article discusses the highlights of "Microbicides 2008" conference held in New Delhi, India from February 24 to 27, 2008. At the event, delegates were told that the completion of the Carraguard trial proved that microbicide studies could be done in a scientifically rigorous and ethical...

  • Weaning Affects HIV Levels in Breast Milk.  // JAMA: Journal of the American Medical Association;6/19/2013, Vol. 309 Issue 23, p2430 

    The article focuses on a clinical trial in Zambia which revealed that changes in breastfeeding routines during weaning influence the concentration of HIV in breast milk.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics